How should granulation tissue at a percutaneous endoscopic gastrostomy (PEG) tube insertion site be treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Granulation Tissue at PEG Tube Insertion Site

Apply topical clobetasol propionate 0.05% cream or ointment twice daily for 7–10 days combined with a foam dressing that provides compression—this resolves hypergranulation tissue in approximately 95.7% of patients with PEG tubes. 1

First-Line Management

Daily Wound Care

  • Clean the peristomal skin at least once daily using an antimicrobial cleanser to reduce bacterial load and control any subclinical colonization 2, 1
  • Apply a zinc-oxide-based barrier film or cream to protect surrounding skin, especially when the granulation tissue is exuding 2, 1
  • Use foam dressings rather than gauze over the affected area—foam lifts drainage away from the skin while gauze causes maceration and adheres to friable tissue, causing trauma upon removal 2, 1

Topical Corticosteroid Therapy

  • Apply clobetasol propionate 0.05% or triamcinolone 0.05% cream/ointment directly to the hypergranulation tissue twice daily 1, 3
  • Cover with a foam dressing to provide gentle compression to the treatment site 2, 1
  • Continue treatment for 7–10 days 2, 1, 3
  • This approach achieves resolution in the vast majority of cases, with only 4.3% requiring escalation to second-line therapy 1

The evidence supporting topical corticosteroids is robust—a 2024 burn center study demonstrated 95.7% resolution rates, and a 2016 case report showed complete resolution within 4 days with no recurrence at 6 months follow-up 1, 3. This makes corticosteroids the clear first-line choice.

Address Mechanical Contributing Factors

Tube Positioning and Tension

  • Verify proper tension between the internal and external bolsters—the external bolster should allow at least 5 mm of free tube movement 2, 1
  • Ensure the tube is not causing excessive pressure or side torsion, which enlarges the stoma tract and promotes granulation tissue formation 2, 1
  • Consider stabilizing the tube with a clamping device or switching to a low-profile device if mechanical factors persist 1

Common Causes to Correct

  • Excess moisture from leakage around the tube 2
  • Excessive friction or movement from a poorly secured tube 2
  • Critical colonization or infection requiring antimicrobial therapy 2

Second-Line Treatment (for the 4.3% Who Fail Corticosteroids)

Silver Nitrate Cauterization

  • Apply silver nitrate directly onto the overgranulation tissue when topical corticosteroids fail after 7–10 days 2, 1
  • This serves as an effective bridge before considering more invasive interventions 1

Third-Line Treatment (for Refractory Cases)

Advanced Interventions

  • Surgical excision of the hypergranulation tissue when both corticosteroids and silver nitrate have failed 2, 1
  • Argon plasma coagulation as an alternative third-line modality for persistent cases 2, 1
  • Consider switching to an alternative brand or type of gastrostomy tube if mechanical failure scenarios persist despite all other interventions 2, 1

The 2022 ESPEN guideline provides the most comprehensive framework, describing this stepwise escalation from topical therapy through cauterization to surgical removal 2. The 2025 AGA update reinforces these principles without contradicting them 2.

Critical Pitfalls to Avoid

What NOT to Do

  • Never use gauze dressings directly on hypergranulation tissue—they adhere to the vascular tissue and cause bleeding and trauma upon removal 1
  • Do not replace the PEG tube with a larger-diameter tube—this enlarges the stoma tract and increases leakage rather than solving the problem 1
  • Avoid hydrogen peroxide after the first week post-placement—it irritates the skin and contributes to stomal complications 2, 1
  • Do not rely on topical antibiotics alone—they are not indicated for hypergranulation management 2
  • Never make the external bolster too tight—excessive pressure between bolsters promotes tissue overgrowth 2

Infection Considerations

  • If active infection is present alongside hypergranulation, apply a topical antimicrobial agent under the fixation device 2, 1
  • Consider foam or silver dressings that provide sustained antimicrobial activity 2
  • Reserve systemic antibiotics for cases where local therapy fails to resolve site infection 2

Algorithm Summary

  1. Start with topical corticosteroid (clobetasol 0.05%) twice daily × 7–10 days + foam dressing + daily antimicrobial cleansing 2, 1, 3
  2. Simultaneously correct mechanical factors (tube tension, movement, moisture) 2, 1
  3. If no improvement after 7–10 days → silver nitrate cauterization 2, 1
  4. If still refractory → surgical excision or argon plasma coagulation 2, 1
  5. Consider tube replacement only as a last resort if all else fails 2, 1

This stepwise approach is supported by the 2022 ESPEN practical guideline on home enteral nutrition, which represents the most current and comprehensive evidence for PEG tube complications 2. The addition of quantitative success rates from the 2024 study provides confidence that the vast majority of patients will respond to first-line corticosteroid therapy 1.

References

Guideline

Management of Hypergranulation Tissue with Active Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.